BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16331626)

  • 1. Development in incidence of breast cancer in non-screened Danish women, 1973-2002--a population-based study.
    Fuglede N; Langballe O; Svendsen AL; Tjønneland A; Dalton SO; Johansen C
    Int J Cancer; 2006 May; 118(9):2366-9. PubMed ID: 16331626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Important increase of invasive lobular breast cancer incidence in Geneva, Switzerland.
    Verkooijen HM; Fioretta G; Vlastos G; Morabia A; Schubert H; Sappino AP; Pelte MF; Schäfer P; Kurtz J; Bouchardy C
    Int J Cancer; 2003 May; 104(6):778-81. PubMed ID: 12640687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing incidence rate of invasive lobular breast carcinoma among older women.
    Li CI; Anderson BO; Porter P; Holt SK; Daling JR; Moe RE
    Cancer; 2000 Jun; 88(11):2561-9. PubMed ID: 10861434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time trends in incidence rates and survival of newly diagnosed stage IV breast cancer by tumor histology: a population-based analysis.
    Di Meglio A; Freedman RA; Lin NU; Barry WT; Metzger-Filho O; Keating NL; King TA; Sertoli MR; Boccardo F; Winer EP; Vaz-Luis I
    Breast Cancer Res Treat; 2016 Jun; 157(3):587-96. PubMed ID: 27271765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of hormone replacement therapy on the histologic subtype of breast cancer.
    Zanetti-Dällenbach RA; Krause EM; Lapaire O; Gueth U; Holzgreve W; Wight E
    Arch Gynecol Obstet; 2008 Nov; 278(5):443-9. PubMed ID: 18335229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and risk factors associated with bilateral breast cancer in area with early age diagnosis but low incidence of primary breast cancer: analysis of 10-year longitudinal cohort in Taiwan.
    Kuo WH; Yen AM; Lee PH; Hou MF; Chen SC; Chen KM; Chen TH; Chang KJ
    Breast Cancer Res Treat; 2006 Sep; 99(2):221-8. PubMed ID: 16544057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An epidemiologic study of differences between mammary ductal and lobular carcinoma in situ: analysis of 11,436 cases from the California Cancer Registry.
    Saltzstein SL
    Anat Pathol; 1996; 1():193-203. PubMed ID: 9390929
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk of breast cancer after exposure to fertility drugs: results from a large Danish cohort study.
    Jensen A; Sharif H; Svare EI; Frederiksen K; Kjaer SK
    Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1400-7. PubMed ID: 17585058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of length of birth interval on the risk of breast cancer by subtype in grand multiparous women.
    Katuwal S; Tapanainen JS; Pukkala E; Kauppila A
    BMC Cancer; 2019 Mar; 19(1):199. PubMed ID: 30832620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting rise in the incidence of infiltrating lobular carcinoma of the breast.
    Chikman B; Lavy R; Davidson T; Wassermann I; Sandbank J; Siegelmann-Danieli N; Halevy A
    Isr Med Assoc J; 2010 Nov; 12(11):697-700. PubMed ID: 21243872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of menopausal hormone therapy on the incidence of different breast cancer types--data from the Cancer Registry Hamburg 1991-2006.
    Hentschel S; Heinz J; Schmid-Höpfner S; Obi N; Vettorazzi E; Chang-Claude J; Flesch-Janys D
    Cancer Epidemiol; 2010 Oct; 34(5):639-43. PubMed ID: 20705533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional variations in breast cancer incidence among California women, 1988-1997.
    Reynolds P; Hurley SE; Quach AT; Rosen H; Von Behren J; Hertz A; Smith D
    Cancer Causes Control; 2005 Mar; 16(2):139-50. PubMed ID: 15868455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bilateral breast cancer.
    Gogas J; Markopoulos C; Skandalakis P; Gogas H
    Am Surg; 1993 Nov; 59(11):733-5. PubMed ID: 8239195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast Cancer in Iranian Woman: Incidence by Age Group, Morphology and Trends.
    Rafiemanesh H; Salehiniya H; Lotfi Z
    Asian Pac J Cancer Prev; 2016; 17(3):1393-7. PubMed ID: 27039778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer incidence after the introduction of mammography screening: what should be expected?
    Svendsen AL; Olsen AH; von Euler-Chelpin M; Lynge E
    Cancer; 2006 May; 106(9):1883-90. PubMed ID: 16572411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening caused rising incidence rates of ductal carcinoma in situ of the breast.
    van Steenbergen LN; Voogd AC; Roukema JA; Louwman WJ; Duijm LE; Coebergh JW; van de Poll-Franse LV
    Breast Cancer Res Treat; 2009 May; 115(1):181-3. PubMed ID: 18516674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk for contralateral breast cancers in a population covered by mammography: effects of family history, age at diagnosis and histology.
    Ji J; Hemminki K
    Breast Cancer Res Treat; 2007 Oct; 105(2):229-36. PubMed ID: 17115107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
    Lynge E
    APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Geographic excess of estrogen receptor-positive breast cancer.
    Benz CC; Clarke CA; Moore DH
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1523-7. PubMed ID: 14693747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Incidence and mortality of breast cancer among women in Denmark 1943-1992].
    Oksbjerg S; Mellemkjoer L; Johansen C
    Ugeskr Laeger; 1997 Nov; 159(48):7134-40. PubMed ID: 9417719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.